Dalton moves into commercial manufacturing services
Canada's Dalton Pharma Services has been given the green light to start offering commercial sterile manufacturing services to its pharma customers.
Canada's Dalton Pharma Services has been given the green light to start offering commercial sterile manufacturing services to its pharma customers.
Nicholas Piramal is planning an acquisition in the US in a move the company hopes will give it the top slot in the custom manufacturing sector.
Major pharmaceutical player GlaxoSmithKline (GSK) has begun construction of a €23m facility in County Waterford, Ireland. The new facility is already under construction at the company's consumer healthcare manufacturing site in Dungarvan.
US-based sterilisation system providers Steris this week announced their fiscal 2007 third quarter results, revealing the impact of the relocation of manufacturing capacity to Mexico and the firm's European restructuring.
Sartorius has reported 7.6 per cent increase in sales revenue in 2006 rising to €520.1m ($677.4m), due to the biotechnology division's decision to focus on disposable systems.
Medifacts International has this week filed for Chapter 11 bankruptcy protection amidst plans to sell off its clinical research services division.